LOC284023 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.635600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.893000E-01
Normal-vs-Stage2
7.436400E-01
Normal-vs-Stage3
8.079200E-03
Normal-vs-Stage4
7.098000E-01
Stage1-vs-Stage2
6.565800E-01
Stage1-vs-Stage3
6.473700E-02
Stage1-vs-Stage4
6.459000E-01
Stage2-vs-Stage3
2.219000E-01
Stage2-vs-Stage4
5.856800E-01
Stage3-vs-Stage4
3.016400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.159200E-01
Normal-vs-AfricanAmerican
3.104200E-01
Normal-vs-Asian
4.467800E-01
Caucasian-vs-AfricanAmerican
6.992000E-01
Caucasian-vs-Asian
4.976400E-01
AfricanAmerican-vs-Asian
9.026000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.076800E-01
Normal-vs-Female
8.347800E-01
Male-vs-Female
5.428600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.643800E-01
Normal-vs-Age(41-60Yrs)
3.982200E-01
Normal-vs-Age(61-80Yrs)
3.367200E-01
Normal-vs-Age(81-100Yrs)
1.859020E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.608600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.452000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.205400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.896390E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.555700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.436200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.384000E-01
Normal-vs-Daily Drinker
8.423600E-01
Normal-vs-Weekly Drinker
9.443000E-01
Normal-vs-Occasional Drinker
4.471600E-01
Normal-vs-Social Drinker
5.926800E-01
Non Drinker-vs-Daily Drinker
4.979600E-01
Non Drinker-vs-Weekly Drinker
3.456000E-01
Non Drinker-vs-Occasional Drinker
9.547200E-01
Non Drinker-vs-Social Drinker
1.956170E-01
Daily Drinker-vs-Weekly Drinker
9.227400E-01
Daily Drinker-vs-Occasional Drinker
4.738000E-01
Daily Drinker-vs-Social Drinker
8.776000E-01
Weekly Drinker-vs-Occasional Drinker
3.347600E-01
Weekly Drinker-vs-Social Drinker
7.348200E-01
Occasional Drinker-vs-Social Drinker
2.343200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.823800E-01
Normal-vs-Grade 2
4.528200E-01
Normal-vs-Grade 3
5.644800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.628600E-01
Grade 1-vs-Grade 3
3.499000E-01
Grade 1-vs-Grade 4
6.823800E-01
Grade 2-vs-Grade 3
4.510600E-01
Grade 2-vs-Grade 4
4.528200E-01
Grade 3-vs-Grade 4
5.644800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.422970E-01
Normal-vs-NonDiabetic
7.356200E-01
Diabetic-vs-NonDiabetic
1.006290E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.170000E-01
Normal-vs-NoPancreatitis
6.283000E-01
Pancreatitis-vs-NoPancreatitis
6.527000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.803800E-01
Normal-vs-N1
3.445800E-01
N0-vs-N1
6.743400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.454850E-01
Normal-vs-TP53-NonMutant
6.088000E-01
TP53-Mutant-vs-TP53-NonMutant
6.964100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
